Clinical trial
Study on the Prevention of Cardiovascular Events by Antiplatelet Agents After Acute Coronary Syndrome
NCT01952392 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study on the Prevention of Cardiovascular Events by Antiplatelet Agents After Acute Coronary Syndrome
- Lead sponsor
- AstraZeneca
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 31, 2013
- Completion date
- March 31, 2016
- Enrollment
- 4,992 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.